Your browser doesn't support javascript.
loading
Papillomavirus, p53 alteration, and primary carcinoma of the vulva.
Pilotti, S; D'Amato, L; Della Torre, G; Donghi, R; Longoni, A; Giarola, M; Sampietro, G; De Palo, G; Pierotti, M A; Rilke, F.
Afiliación
  • Pilotti S; Division of Anatomical Pathology and Cytology, Istituto Nazionale Tumori, Milan, Italy.
Diagn Mol Pathol ; 4(4): 239-48, 1995 Dec.
Article en En | MEDLINE | ID: mdl-8634779
Twenty-nine samples from 28 cases of vulvar squamous cell carcinoma, of which 13 fulfilled the criteria of the bowenoid subtype (mean age 45 years, range 31-68) and 16 of the usual subtype of invasive squamous cell carcinoma (ISCC) (mean age 67.5 years, range 34-83) were investigated for human papillomavirus (HPV) DNA, TP53 alterations, and mdm2 and bcl-2 gene product deregulation. Microscopically all the bowenoid subtype cases (group I) showed a high-grade intraepithelial (VIN 3, carcinoma in situ) lesion associated with early invasive carcinoma in six cases and overt invasive carcinoma in one. By contrast, no evidence of early carcinoma was present in the ISCCs (group II). By in situ hybridization and/or Southern blot hybridization or polymerase chain reaction (PCR), HPV DNA was detected in all cases of group I and in four of 16 cases (25%) of group II, two only by Southern blot after PCR. By single-strand conformation polymorphism and immunocytochemistry only wild-type TP53 and absence of detectable p53 product, respectively, were found in all cases of group I, i.e., in high-risk HPV-positive carcinomas, whereas mutations and/or p53 overexpression accounted for 75% in group II, i.e., in mainly HPV-negative carcinomas. The TP53 gene mutations observed in invasive carcinomas were significantly related to node-positive cases (p = 0.04). Taken together and in agreement with in vitro data, these results support the view that an alteration of TP53, gained either by interaction with viral oncoproteins or by somatic mutations, is a crucial event in the pathogenesis of vulvar carcinomas, but that TP53 mutations are mainly associated with disease progression. Finally, a preliminary immunocytochemical analysis seems to speak against the possible involvement of both MDM2 and BCL-2 gene products in the development of vulvar carcinoma.
Asunto(s)
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Papillomaviridae / Infecciones Tumorales por Virus / Neoplasias de la Vulva / Carcinoma de Células Escamosas / Displasia del Cuello del Útero / Genes p53 / Infecciones por Papillomavirus Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Diagn Mol Pathol Asunto de la revista: BIOLOGIA MOLECULAR / PATOLOGIA Año: 1995 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Estados Unidos
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Papillomaviridae / Infecciones Tumorales por Virus / Neoplasias de la Vulva / Carcinoma de Células Escamosas / Displasia del Cuello del Útero / Genes p53 / Infecciones por Papillomavirus Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Diagn Mol Pathol Asunto de la revista: BIOLOGIA MOLECULAR / PATOLOGIA Año: 1995 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Estados Unidos